CRISPR Therapeutics AG
CRSP
$56.25
-$0.43-0.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.30% | -7.23% | -2.55% | -1.64% | -3.30% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.67% | 1.17% | 42.22% | -24.74% | -6.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | -- | -- | -- |
| Total Current Assets | 11.27% | -7.17% | -3.59% | -0.35% | -3.31% |
|
|
|||||
| Total Current Assets | 11.27% | -7.17% | -3.59% | -0.35% | -3.31% |
| Net Property, Plant & Equipment | -2.70% | -2.65% | -2.83% | -2.55% | -2.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.70% | -62.21% | 5.27% | -0.23% | 2.81% |
| Total Assets | 10.62% | -6.30% | -3.39% | -0.62% | -3.58% |
|
|
|||||
| Total Accounts Payable | 20.97% | -25.34% | -11.18% | -5.58% | 64.81% |
| Total Accrued Expenses | -9.02% | -3.24% | -28.22% | 10.84% | -8.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.27% | 2.98% | 1.26% | 2.40% | 2.63% |
| Total Finance Division Other Current Liabilities | 30.05% | -18.78% | 269.97% | -24.86% | -65.33% |
| Total Other Current Liabilities | 30.05% | -18.78% | 269.97% | -24.86% | -65.33% |
| Total Current Liabilities | 13.98% | -12.63% | 36.07% | -2.26% | -29.74% |
|
|
|||||
| Total Current Liabilities | 13.98% | -12.63% | 36.07% | -2.26% | -29.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.36% | -2.19% | -2.21% | -2.02% | -1.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.77% | 7.39% | -0.79% | -1.46% | -1.41% |
| Total Liabilities | 3.37% | -5.45% | 8.71% | -2.06% | -11.82% |
|
|
|||||
| Common Stock & APIC | 9.08% | 2.72% | 0.93% | 1.18% | 0.97% |
| Retained Earnings | -6.22% | -13.89% | -9.96% | -2.81% | -6.92% |
| Treasury Stock & Other | 23.80% | -2.31% | 129.08% | -83.07% | 457.12% |
| Total Common Equity | 11.97% | -6.45% | -5.33% | -0.39% | -2.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.97% | -6.45% | -5.33% | -0.39% | -2.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.97% | -6.45% | -5.33% | -0.39% | -2.08% |
|
|
|||||